(Q39017874)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

8 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

RGD-FasL induces apoptosis in hepatocellular carcinoma (English)

1 reference

8 September 2017

Zhongchen Liu

1

1 reference

8 September 2017

Juan Wang

2

1 reference

8 September 2017

Ping Yin

3

1 reference

8 September 2017

Jinhua Qiu

4

1 reference

8 September 2017

Ruizhen Liu

5

1 reference

8 September 2017

Wenzhu Li

6

1 reference

8 September 2017

Xin Fan

7

1 reference

8 September 2017

Xiaofeng Cheng

8

1 reference

8 September 2017

Caixia Chen

9

1 reference

8 September 2017

Jiakai Zhang

10

1 reference

8 September 2017

Guohong Zhuang

11

1 reference

8 September 2017

1 August 2009

1 reference

Cellular and Molecular Immunology

8 September 2017

1 reference

8 September 2017

6

1 reference

8 September 2017

4

1 reference

8 September 2017

285-293

1 reference

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

8 September 2017

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Synthetic RGD-containing alpha-helical coiled coil peptides promote integrin-dependent cell adhesion

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Integrins in drug targeting-RGD templates in toxins

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Cloak and dagger in the avoidance of immune surveillance

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

A role for CD95 ligand in preventing graft rejection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

A novel Mutein of TNFalpha Containing the Arg-Gly-Asp Sequence Shows Reduced Toxicity in Intestine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Body distributioin of RGD-mediated liposome in brain-targeting drug delivery

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Alpha v integrins as receptors for tumor targeting by circulating ligands.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Overcoming the metastasis-enhancing potential of human tumor necrosis factor alpha by introducing the cell-adhesive Arg-Gly-Asp sequence

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Intrahepatic chemotherapy for unresectable hepatocellular carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Novel muteins of human tumor necrosis factor with potent antitumor activity and less lethal toxicity in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Novel mutein of tumor necrosis factor alpha (F4614) with reduced hypotensive effect

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1038/CMI.2009.38

Identifiers

DOI

10.1038/CMI.2009.38

1 reference

8 September 2017

1 reference

8 September 2017

PubMed publication ID

19728930

1 reference